Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (3)
Type
(
1 selected
)
Type
Guidance (761)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (761)
Apply filters
Showing 561 to 570 of 761
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis
TA386
23 March 2016
23 March 2016
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)
TA23
26 April 2001
3 March 2016
Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia
TA385
24 February 2016
24 February 2016
Nivolumab for treating advanced (unresectable or metastatic) melanoma
TA384
18 February 2016
18 February 2016
TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis
TA383
1 February 2016
1 February 2016
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
TA377
27 January 2016
27 January 2016
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy
TA378
27 January 2016
27 January 2016
Nintedanib for treating idiopathic pulmonary fibrosis
TA379
27 January 2016
27 January 2016
Panobinostat for treating multiple myeloma after at least 2 previous treatments
TA380
27 January 2016
27 January 2016
Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal)
TA382
27 January 2016
27 January 2016
Previous page
1
…
55
56
Current page
57
58
59
…
77
Page
57
of
77
Next page
Results per page
10
25
50
All
Back to top